An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
This study has been completed.
Sponsor:
Tillotts Pharma AG
Information provided by:
Tillotts Pharma AG
ClinicalTrials.gov Identifier:
NCT00074542
First received: December 15, 2003
Last updated: February 20, 2007
Last verified: October 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | January 2005 |
| Estimated Primary Completion Date: | No date given |
No publications provided by Tillotts Pharma AG
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):